Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Overview
RGX-202 (?-GPA) is a creatine analog that alters skeletal muscle energy expenditure. It reduces cellular ATP, creatine, and phosphocreatine levels and stimulates AMP-activated protein kinase (AMPK), activating PPAR? coactivator 1? (PGC-1?).
Chemical Properties
| Molecular Formula | C4H9N3O2 |
| Molecular Weight | 131.13 |
| CAS Numbers | 353-09-3 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CC(O)=O)NC(=N)N |
Storage and Handling
0C Short Term, -20C Long Term
References
Oudman I, Clark JF, Brewster LM.The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism a systematic review.PLoS One. 2013;8[1] e52879.